It is being carried by carrier airline Air India.
Covishield and Covaxin, the two Covid-19 vaccines which have received Emergency Use Authorisation (EAU) have been tested on thousands of people and side-effects are negligible, Dr VK Paul, Member (Health), NITI Aayog, said on Tuesday.
He noted that the two ‘are safest of the vaccines’.
“Both the vaccines (Covishield and Covaxin) have been authorized for emergency use and there should be no doubt about their safety. They have been tested on thousands of people and side-effects are negligible. There is no risk of any significance,” Dr Paul said at a press conference.
The first phase of the Covid-19 vaccination drive is scheduled to start from January 16.
Health Secretary Rajesh Bhushan said that the Central government is having close collaboration with states and union territories for vaccine roll-out. “All preparations are on track for vaccine roll-out from January 16,” he said.
Health experts term Covid-19 vaccination drive as great achievement for India
As India is all set to start the biggest Covid-19 vaccination drive from January 16, the health experts working at several Delhi-NCR hospitals have termed it as a great achievement and are hopeful of a positive outcome.
The experts said that India has experienced a massive vaccination drive but there is a need to ensure the proper arrangements for a smooth vaccination drive which will help in removing the fear of Covid-19.
Dr Shuchin Bajaj, Founder and Director, Ujala Cygnus Group of Hospitals, New Delhi said that country is looking forward to vaccinate about 300 million people by the end of August.
Dr P Venkata Krishnan, Senior Consultant- Internal Medicine, Paras Hospital, Gurugram said India is leading the process of vaccine development all over the world and it is soon going to become the hub of the Covid vaccine for the entire world.
Earlier in the day, Union Health Secretary Rajesh Bhushan said the central government is having close collaboration with states/UTs for vaccine roll-out. “All preparations are on track for vaccine roll-out from January 16, 2021,” he said.
He said the Covid-19 vaccine may cost in the range of Rs 200 to 295 in India and two vaccines — Covishiled and Covaxin — have received Emergency Use Authorisation (EAU) after going through established safety and immunogenicity in a well-prescribed regulatory process.
(With inputs from agencies)